Last reviewed · How we verify
NCT05670873: I-HELP
Transcranial Magnetic Stimulation in Disorder of Consciousness in Acute Severe Cerebrovascular Disease Patients
NA trial testing Transcranial magnetic stimulation in Ischemic Stroke in 50 participants. Not yet recruiting.
1 January 2026
Quick facts
| Lead sponsor | Liping Liu |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 March 2023 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 June 2026 |
Drugs / interventions tested
- Transcranial magnetic stimulation — full drug profile →
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Consciousness Disorder — all drugs for Consciousness Disorder →
- Transcranial Magnetic Stimulation — all drugs for Transcranial Magnetic Stimulation →
Sponsor
Liping Liu
Who can join
Adults 18 to 80, any sex, with Ischemic Stroke or Consciousness Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aimed at evaluating the potential of transcranial magnetic stimulation in patients with acute severe ischemic stroke with DoC while assessing patients with a hybrid neural network evaluation model. This model may be the basis for initiating individualized closed-loop neuromodulation treatment in patients with DoC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05670873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial magnetic stimulation
Trials testing the same drug.
- NCT07167940 — Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days · Phase 3 · not yet recruiting
- NCT07035119 — Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07369960 — Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Glo · NA · recruiting
- NCT07085910 — Hebbian-Type Associative Stimulation in Stroke Rehabilitation · NA · not yet recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other Liping Liu trials
Trials by the same sponsor.
- NCT05676957 — Reperfusion With Hypothermia in Acute Ischemic Stroke · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05670873 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liping Liu
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing